Clinical Trials
63 trialsA Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Heroine01
Advanced Imaging Projects, LLC
HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients
Gadjah Mada University
Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer
Fudan University
CINDERELLA
Fudan University
IMX-110 in Patients With Advanced Solid Tumors
Immix Biopharma, Inc.
A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Study of TFX06 in Women With Advanced Breast Cancer.
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
Chongqing Precision Biotech Co., Ltd
A Phase â… b/â…¡ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.
Jiangsu HengRui Medicine Co., Ltd.
PLEASURABLE
Fudan University
Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
G1 Therapeutics, Inc.
Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases
Fudan University
68Ga PET/CT Imaging in Breast Cancer Patients
Peking Union Medical College Hospital
A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients
Yonsei University
ImmunoBreast - A Phase Ib Study
Odense University Hospital
A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients
Immunicom Inc
ENZENO
EnhancedBio Inc.
METROmaJX
Institut Bergonié
KORNELIA
Seoul National University Hospital
Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c
Ahon Pharmaceutical Co., Ltd.
Multi-4SCAR-T Therapy Targeting Breast Cancer
Shenzhen Geno-Immune Medical Institute
4SCAR-CD44v6 T Cell Therapy Targeting Cancer
Shenzhen Geno-Immune Medical Institute
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Petra Pharma
Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer
Peking Union Medical College
Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer
West China Hospital
Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor
Tel-Aviv Sourasky Medical Center
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells
Xuanwu Hospital, Beijing
Circadian Thermal Sensing to Detect Breast Disease
Cyrcadia Health
Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer
Academic Emergency County Hospital Sibiu
Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
Poveda, Andrés, M.D.
Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer
National University Hospital, Singapore
The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer Patients
Lagos State University
The Breast Surgery EnLight and LightPath Imaging System Study
Lightpoint Medical Limited
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors
Sun Yat-sen University
NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer
National University Hospital, Singapore
Limiting Chemotherapy Side Effects by Using Moxa
East and North Hertfordshire NHS Trust
MANTICORE
AHS Cancer Control Alberta
VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer
Vestan, Inc.
Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers
Arno Therapeutics
A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors
Hanmi Pharmaceutical Company Limited
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Rutgers, The State University of New Jersey
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
National Cancer Institute (NCI)
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Biological Therapy in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Clinical Trial of SAHA in Patients With Breast Cancer
National University Hospital, Singapore